Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of the Orexin 1 Receptor is a Critical Component of CO2-Mediated Anxiety and Hypertension but not Bradycardia
Philip L. Johnson, Brian C. Samuels, Stephanie D. Fitz, et al.
Neuropsychopharmacology (2012) Vol. 37, Iss. 8, pp. 1911-1922
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition
Borwin Bandelow, David S. Baldwin, Marianna Abelli, et al.
The World Journal of Biological Psychiatry (2016) Vol. 18, Iss. 3, pp. 162-214
Open Access | Times Cited: 296
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
George F. Koob
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 163-201
Open Access | Times Cited: 233
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Orexin, stress, and anxiety/panic states
Philip L. Johnson, Andrei I. Molosh, Stephanie D. Fitz, et al.
Progress in brain research (2012), pp. 133-161
Open Access | Times Cited: 200
Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus
Robert M. Sears, Ann E. Fink, Mattis B. Wigestrand, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 50, pp. 20260-20265
Open Access | Times Cited: 178
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia
Paul J. Coleman, Anthony L. Gotter, W. Joseph Herring, et al.
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 509-533
Closed Access | Times Cited: 113
To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance
Juliette A. Brown, Hillary L. Woodworth, Gina M. Leinninger
Frontiers in Systems Neuroscience (2015) Vol. 9
Open Access | Times Cited: 95
Orexins and fear: implications for the treatment of anxiety disorders
África Flores, Rocío Saravia, Rafaël Maldonado, et al.
Trends in Neurosciences (2015) Vol. 38, Iss. 9, pp. 550-559
Open Access | Times Cited: 92
The role of the orexin system in stress response
Derya Sargin
Neuropharmacology (2018) Vol. 154, pp. 68-78
Closed Access | Times Cited: 90
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
Identification of a novel perifornical-hypothalamic-area-projecting serotonergic system that inhibits innate panic and conditioned fear responses
Cristian Bernabe, Izabela Facco Caliman, Aline Rezende Abreu, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Orexin 1 receptors are a novel target to modulate panic responses and the panic brain network
Philip L. Johnson, Brian C. Samuels, Stephanie D. Fitz, et al.
Physiology & Behavior (2012) Vol. 107, Iss. 5, pp. 733-742
Open Access | Times Cited: 102
Role of Orexin in the Pathophysiology of Depression: Potential for Pharmacological Intervention
Mathieu Nollet, Samuel Leman
CNS Drugs (2013) Vol. 27, Iss. 6, pp. 411-422
Closed Access | Times Cited: 80
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Quanhui Chen, Luı́s de Lecea, Zhian Hu, et al.
Medicinal Research Reviews (2014) Vol. 35, Iss. 1, pp. 152-197
Closed Access | Times Cited: 79
The brain orexin system and almorexant in fear-conditioned startle reactions in the rat
Michel A. Steiner, Hugues Lecourt, François Jenck
Psychopharmacology (2012) Vol. 223, Iss. 4, pp. 465-475
Closed Access | Times Cited: 78
Dorsal Raphe Serotonin Neurons Mediate CO2-Induced Arousal from Sleep
Haleigh R. Smith, Nicole Leibold, Daniel A. Rappoport, et al.
Journal of Neuroscience (2018) Vol. 38, Iss. 8, pp. 1915-1925
Open Access | Times Cited: 73
Selective orexin receptor antagonists
Terry P. Lebold, Pascal Bonaventure, Brock T. Shireman
Bioorganic & Medicinal Chemistry Letters (2013) Vol. 23, Iss. 17, pp. 4761-4769
Closed Access | Times Cited: 73
The Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468
Alexander Treiber, Ruben de Kanter, Catherine Roch, et al.
Journal of Pharmacology and Experimental Therapeutics (2017) Vol. 362, Iss. 3, pp. 489-503
Open Access | Times Cited: 69
Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy
Cliff H. Summers, Jazmine D. W. Yaeger, Clarissa D. Staton, et al.
Brain Research (2018) Vol. 1731, pp. 146085-146085
Open Access | Times Cited: 59
Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala
David H. Arendt, James E. Hassell, Hao Li, et al.
Psychoneuroendocrinology (2013) Vol. 40, pp. 17-26
Open Access | Times Cited: 66
5-HT2A receptor activation is necessary for CO2-induced arousal
Gordon F. Buchanan, Haleigh R. Smith, Amanda MacAskill, et al.
Journal of Neurophysiology (2015) Vol. 114, Iss. 1, pp. 233-243
Open Access | Times Cited: 63
OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2-INDUCED PANIC-ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES
Philip L. Johnson, Lauren M. Federici, Stephanie D. Fitz, et al.
Depression and Anxiety (2015) Vol. 32, Iss. 9, pp. 671-683
Open Access | Times Cited: 62
OX1 and OX2 orexin/hypocretin receptor pharmacogenetics
Miles D. Thompson, Henri Xhaard, Takeshi Sakurai, et al.
Frontiers in Neuroscience (2014) Vol. 8
Open Access | Times Cited: 61
Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks
Philip L. Johnson, Lauren M. Federici, Anantha Shekhar
Neuroscience & Biobehavioral Reviews (2014) Vol. 46, pp. 429-454
Open Access | Times Cited: 58
Orexin, orexin receptor antagonists and central cardiovascular control
Pascal Carrive
Frontiers in Neuroscience (2013) Vol. 7
Open Access | Times Cited: 57
Page 1 - Next Page

Scroll to top